Carregant...
OP15. Enhancement of Myeloid Dendritic Cells through MAPK p38 inhibition Promotes T cell Proliferation and Restores Adaptive Immunity in GBM Patients
INTRODUCTION: Immunotherapy is an emerging backbone to oncology treatment in a number of cancers, mainly due to the advent of checkpoint blockade therapy. In Glioblastoma (GBM) immunotherapies such as peptide vaccines and laboratory generated monocyte-derived dendritic cells (moDC) are demonstrating...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358585/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now292.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|